We are live on ! Find out more
RH

Rayner & Haynor Portfolio holdings

AUM $131M
1-Year Est. Return 11.41%
This Fund
S&P 500
This Quarter Est. Return
-1.48%
1 Year Est. Return
+11.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$131M
AUM Growth
-$1.85M
Cap. Flow
+$524K
Cap. Flow %
0.4%
Top 10 Hldgs %
44.04%
Holding
92
New
2
Increased
7
Reduced
44
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 11.09%
2 Healthcare 10.46%
3 Consumer Staples 6.6%
4 Energy 6.38%
5 Industrials 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
26
Apple
AAPL
$4.9T
$1.47M 1.12%
58,180
-400
-0.7% -$9.82K
CL icon
27
Colgate-Palmolive
CL
$74.4B
$1.41M 1.08%
21,570
SCHB icon
28
Schwab US Broad Market ETF
SCHB
$43B
$1.36M 1.04%
171,420
+7,200
+4% +$57.6K
ETN icon
29
Eaton
ETN
$155B
$1.28M 0.98%
20,270
-600
-3% -$42.5K
TGT icon
30
Target
TGT
$63.4B
$1.25M 0.96%
20,000
-100
-0.5% -$6.06K
MSFT icon
31
Microsoft
MSFT
$2.93T
$1.2M 0.92%
25,950
DD
32
DELISTED
Du Pont De Nemours E I
DD
$1.11M 0.85%
16,333
WFC icon
33
Wells Fargo
WFC
$265B
$1.09M 0.84%
21,100
-200
-0.9% -$10.3K
LH icon
34
Labcorp
LH
$23.2B
$1.05M 0.8%
12,001
-87
-0.7% -$7.86K
DHR icon
35
Danaher
DHR
$144B
$1.02M 0.78%
20,041
VYM icon
36
Vanguard High Dividend Yield ETF
VYM
$80B
$980K 0.75%
14,750
+1,925
+15% +$128K
VSS icon
37
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.3B
$977K 0.75%
9,570
-250
-3% -$27.1K
DOC icon
38
Healthpeak Properties
DOC
$15.5B
$943K 0.72%
26,078
-365
-1% -$13.8K
FLR icon
39
Fluor
FLR
$6.85B
$943K 0.72%
14,120
-100
-0.7% -$7.36K
GLD icon
40
SPDR Gold Trust
GLD
$130B
$910K 0.7%
7,830
ABT icon
41
Abbott
ABT
$175B
$877K 0.67%
21,075
-300
-1% -$12.7K
USB icon
42
US Bancorp
USB
$98.4B
$869K 0.67%
20,772
IFF icon
43
International Flavors & Fragrances
IFF
$20B
$849K 0.65%
8,850
LHX icon
44
L3Harris
LHX
$52.5B
$845K 0.65%
12,720
-150
-1% -$10.6K
ABBV icon
45
AbbVie
ABBV
$450B
$796K 0.61%
13,775
-450
-3% -$25K
PRU icon
46
Prudential Financial
PRU
$41.4B
$771K 0.59%
8,771
-75
-0.8% -$6.71K
TEVA icon
47
Teva Pharmaceuticals
TEVA
$37.3B
$742K 0.57%
13,800
-425
-3% -$22.5K
CSCO icon
48
Cisco
CSCO
$441B
$737K 0.56%
29,280
GD icon
49
General Dynamics
GD
$99.7B
$715K 0.55%
5,625
-50
-0.9% -$6.07K
VOE icon
50
Vanguard Mid-Cap Value ETF
VOE
$23.5B
$713K 0.55%
8,400

Similar funds

Rayner & Haynor's Q3 2014 Portfolio in Review

As of Q3 2014, Rayner & Haynor held 92 positions worth $131M, down 1.4% from $132M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 3.3%. Rayner & Haynor opened 2 new positions and exited 1, leaving the 92-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Rayner & Haynor's largest Q3 2014 buy was Potash Corp Of Saskatchewan: 10,300 shares worth $356K.
  • Rayner & Haynor added most to Vanguard Short-Term Bond ETF in Q3 2014, an estimated $806K increase.
  • Rayner & Haynor's biggest Q3 2014 reduction was Vanguard Large-Cap ETF, cutting an estimated $166K.
  • Rayner & Haynor fully exited State Street SPDR S&P 500 ETF Trust in Q3 2014, selling an estimated $239K.
  • Rayner & Haynor's ten largest holdings make up 44% of its $131M portfolio in Q3 2014.
  • Rayner & Haynor opened 2 new positions and closed 1 in Q3 2014.
  • Rayner & Haynor's portfolio value fell 1.4% quarter-over-quarter to $131M.

Based on Rayner & Haynor's 13F filing for Q3 2014, filed 14 Nov 2014.